nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—blood—schizophrenia	0.0351	0.214	CbGeAlD
Tasosartan—AGTR2—endocrine gland—schizophrenia	0.0304	0.186	CbGeAlD
Tasosartan—AGTR1—blood plasma—schizophrenia	0.0214	0.131	CbGeAlD
Tasosartan—CYP3A4—urine—schizophrenia	0.0151	0.0922	CbGeAlD
Tasosartan—AGTR1—forebrain—schizophrenia	0.0117	0.0718	CbGeAlD
Tasosartan—CYP3A4—blood plasma—schizophrenia	0.00787	0.0481	CbGeAlD
Tasosartan—AGTR1—blood—schizophrenia	0.00786	0.048	CbGeAlD
Tasosartan—AGTR1—endocrine gland—schizophrenia	0.00681	0.0416	CbGeAlD
Tasosartan—AGTR1—nervous system—schizophrenia	0.00638	0.039	CbGeAlD
Tasosartan—AGTR1—central nervous system—schizophrenia	0.00614	0.0375	CbGeAlD
Tasosartan—AGTR1—brain—schizophrenia	0.00487	0.0298	CbGeAlD
Tasosartan—Irbesartan—CYP1A2—schizophrenia	0.00378	0.236	CrCbGaD
Tasosartan—Losartan—ACE—schizophrenia	0.00343	0.215	CrCbGaD
Tasosartan—Irbesartan—CYP2D6—schizophrenia	0.00291	0.182	CrCbGaD
Tasosartan—CYP3A4—blood—schizophrenia	0.00288	0.0176	CbGeAlD
Tasosartan—CYP3A4—endocrine gland—schizophrenia	0.0025	0.0153	CbGeAlD
Tasosartan—Losartan—CYP1A2—schizophrenia	0.00243	0.152	CrCbGaD
Tasosartan—CYP3A4—nervous system—schizophrenia	0.00234	0.0143	CbGeAlD
Tasosartan—CYP3A4—central nervous system—schizophrenia	0.00225	0.0138	CbGeAlD
Tasosartan—Candesartan—ABCB1—schizophrenia	0.00208	0.13	CrCbGaD
Tasosartan—Losartan—ABCB1—schizophrenia	0.00134	0.084	CrCbGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00112	0.00137	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GRM5—schizophrenia	0.00112	0.00136	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCK—schizophrenia	0.0011	0.00134	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00109	0.00132	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—schizophrenia	0.00108	0.00132	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TLE3—schizophrenia	0.00108	0.00132	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00106	0.00129	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCKAR—schizophrenia	0.00105	0.00128	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00104	0.00127	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00103	0.00125	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCK—schizophrenia	0.00102	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADORA2A—schizophrenia	0.00102	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00101	0.00123	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDE4B—schizophrenia	0.000995	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GRM2—schizophrenia	0.000989	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—TAAR6—schizophrenia	0.000989	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.000983	0.0012	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.000983	0.0012	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCKAR—schizophrenia	0.000978	0.00119	CbGpPWpGaD
Tasosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—schizophrenia	0.000956	0.00117	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—FZD3—schizophrenia	0.000955	0.00116	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—NPY—schizophrenia	0.000953	0.00116	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADORA2A—schizophrenia	0.000949	0.00116	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PLA2G4A—schizophrenia	0.000933	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00093	0.00113	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR1B—schizophrenia	0.000919	0.00112	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—OXT—schizophrenia	0.000919	0.00112	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NGEF—schizophrenia	0.000915	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FGA—schizophrenia	0.00091	0.00111	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—HTR2A—schizophrenia	0.000909	0.00111	CbGpPWpGaD
Tasosartan—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	0.000898	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP3CC—schizophrenia	0.000898	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TAAR6—schizophrenia	0.000898	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GRM2—schizophrenia	0.000898	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NTS—schizophrenia	0.000894	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Allograft Rejection—TNF—schizophrenia	0.000891	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NPY—schizophrenia	0.000886	0.00108	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ATP2A2—schizophrenia	0.000886	0.00108	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOTCH4—schizophrenia	0.000886	0.00108	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR1A—schizophrenia	0.000885	0.00108	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—NDST3—schizophrenia	0.000873	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—NPS—schizophrenia	0.000871	0.00106	CbGpPWpGaD
Tasosartan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.000856	0.00104	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR1B—schizophrenia	0.000855	0.00104	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—OXT—schizophrenia	0.000855	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—DRD1—schizophrenia	0.000855	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR2C—schizophrenia	0.000855	0.00104	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CYP1A2—schizophrenia	0.000851	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RGS4—schizophrenia	0.000841	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GRM3—schizophrenia	0.000841	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NGEF—schizophrenia	0.000831	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—DRD3—schizophrenia	0.000828	0.00101	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HTR2A—schizophrenia	0.000826	0.00101	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR6—schizophrenia	0.000825	0.00101	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR1A—schizophrenia	0.000823	0.001	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NTS—schizophrenia	0.000812	0.00099	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NPS—schizophrenia	0.000811	0.000988	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.000803	0.000979	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—DRD4—schizophrenia	0.000803	0.000979	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DRD1—schizophrenia	0.000795	0.000969	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR2C—schizophrenia	0.000795	0.000969	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK2—schizophrenia	0.000773	0.000943	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DRD3—schizophrenia	0.00077	0.000939	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CNR1—schizophrenia	0.000767	0.000935	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GRM3—schizophrenia	0.000764	0.000931	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RGS4—schizophrenia	0.000764	0.000931	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.000761	0.000927	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.000751	0.000915	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR6—schizophrenia	0.000749	0.000914	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—DRD2—schizophrenia	0.000748	0.000912	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR7—schizophrenia	0.000748	0.000912	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DRD4—schizophrenia	0.000748	0.000911	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CHRM1—schizophrenia	0.000729	0.000889	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CNR1—schizophrenia	0.000714	0.00087	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL3RA—schizophrenia	0.00071	0.000866	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DRD2—schizophrenia	0.000696	0.000849	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR7—schizophrenia	0.000696	0.000849	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.000688	0.000839	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.000688	0.000839	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.000679	0.000828	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GRM5—schizophrenia	0.000678	0.000826	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DGKI—schizophrenia	0.000664	0.000809	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CHRM1—schizophrenia	0.000662	0.000807	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRL—schizophrenia	0.000658	0.000802	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL3RA—schizophrenia	0.000645	0.000786	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCK—schizophrenia	0.00062	0.000756	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000617	0.000752	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GRM5—schizophrenia	0.000615	0.00075	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—S100B—schizophrenia	0.000613	0.000747	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP1R1B—schizophrenia	0.000607	0.00074	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP26B1—schizophrenia	0.000607	0.000739	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PDE4B—schizophrenia	0.000604	0.000736	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP26B1—schizophrenia	0.000598	0.000729	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCKAR—schizophrenia	0.000594	0.000724	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB4—schizophrenia	0.000586	0.000715	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000576	0.000702	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FZD3—schizophrenia	0.000564	0.000688	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCK—schizophrenia	0.000563	0.000686	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.000558	0.00068	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PLA2G4A—schizophrenia	0.000551	0.000672	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PDE4B—schizophrenia	0.000549	0.000669	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NRG1—schizophrenia	0.000541	0.000659	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GCLM—schizophrenia	0.000541	0.000659	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCKAR—schizophrenia	0.00054	0.000658	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPY—schizophrenia	0.000538	0.000656	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MEF2C—schizophrenia	0.000536	0.000653	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP3CC—schizophrenia	0.00053	0.000647	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FES—schizophrenia	0.00053	0.000647	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TAAR6—schizophrenia	0.00053	0.000647	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM2—schizophrenia	0.00053	0.000647	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR2A—schizophrenia	0.000524	0.000639	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADORA2A—schizophrenia	0.000523	0.000638	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OXT—schizophrenia	0.000519	0.000633	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR1B—schizophrenia	0.000519	0.000633	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—YWHAZ—schizophrenia	0.000518	0.000632	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ERBB3—schizophrenia	0.000507	0.000618	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR1A—schizophrenia	0.0005	0.00061	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPS—schizophrenia	0.000492	0.0006	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NGEF—schizophrenia	0.000491	0.000598	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPY—schizophrenia	0.000489	0.000596	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR2A—schizophrenia	0.000488	0.000595	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—DRD1—schizophrenia	0.000483	0.000589	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2C—schizophrenia	0.000483	0.000589	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTS—schizophrenia	0.00048	0.000585	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR1B—schizophrenia	0.000472	0.000575	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OXT—schizophrenia	0.000472	0.000575	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—DRD3—schizophrenia	0.000468	0.00057	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.000464	0.000566	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR1A—schizophrenia	0.000454	0.000554	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—DRD4—schizophrenia	0.000454	0.000553	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOE—schizophrenia	0.000453	0.000553	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RGS4—schizophrenia	0.000451	0.00055	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM3—schizophrenia	0.000451	0.00055	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RTN4—schizophrenia	0.000451	0.00055	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOA1—schizophrenia	0.000448	0.000546	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPS—schizophrenia	0.000447	0.000545	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR6—schizophrenia	0.000443	0.00054	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2C—schizophrenia	0.000439	0.000535	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—DRD1—schizophrenia	0.000439	0.000535	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CNR1—schizophrenia	0.000434	0.000528	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ESR1—schizophrenia	0.000433	0.000528	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAG—schizophrenia	0.000428	0.000521	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—DRD3—schizophrenia	0.000425	0.000518	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR7—schizophrenia	0.000423	0.000516	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—DRD2—schizophrenia	0.000423	0.000516	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—DRD4—schizophrenia	0.000412	0.000503	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CNR1—schizophrenia	0.000394	0.00048	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GSK3B—schizophrenia	0.000393	0.000479	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CHRM1—schizophrenia	0.000391	0.000477	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR7—schizophrenia	0.000384	0.000468	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—DRD2—schizophrenia	0.000384	0.000468	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL3RA—schizophrenia	0.000381	0.000465	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRG3—schizophrenia	0.000372	0.000453	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TLE1—schizophrenia	0.000372	0.000453	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GFAP—schizophrenia	0.000368	0.000448	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM5—schizophrenia	0.000364	0.000443	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TLE3—schizophrenia	0.000352	0.000429	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCK—schizophrenia	0.000333	0.000405	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	0.000328	0.000399	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4B—schizophrenia	0.000324	0.000395	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	0.000323	0.000394	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCKAR—schizophrenia	0.000319	0.000389	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADORA2A—schizophrenia	0.000309	0.000377	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000304	0.000371	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FGA—schizophrenia	0.000296	0.000361	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	0.000296	0.000361	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2A—schizophrenia	0.000296	0.000361	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	0.000292	0.000356	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AKT1—schizophrenia	0.000291	0.000355	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOTCH4—schizophrenia	0.000289	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPY—schizophrenia	0.000289	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ATP2A2—schizophrenia	0.000289	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OXT—schizophrenia	0.000279	0.00034	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR1B—schizophrenia	0.000279	0.00034	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2A—schizophrenia	0.000269	0.000328	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR1A—schizophrenia	0.000268	0.000327	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AKT1—schizophrenia	0.000264	0.000322	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPS—schizophrenia	0.000264	0.000322	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2C—schizophrenia	0.000259	0.000316	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD1—schizophrenia	0.000259	0.000316	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EP300—schizophrenia	0.000258	0.000315	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK2—schizophrenia	0.000252	0.000307	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD3—schizophrenia	0.000251	0.000306	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—COMT—schizophrenia	0.000248	0.000303	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—schizophrenia	0.000247	0.000301	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—MAOA—schizophrenia	0.000247	0.0003	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	0.000245	0.000298	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	0.000244	0.000297	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD4—schizophrenia	0.000244	0.000297	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CNR1—schizophrenia	0.000233	0.000284	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—schizophrenia	0.000227	0.000277	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR7—schizophrenia	0.000227	0.000277	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD2—schizophrenia	0.000227	0.000277	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	0.000224	0.000273	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRL—schizophrenia	0.000214	0.000261	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRODH—schizophrenia	0.000212	0.000259	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—S100B—schizophrenia	0.0002	0.000243	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB4—schizophrenia	0.000191	0.000233	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TP53—schizophrenia	0.000185	0.000225	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLA2G4A—schizophrenia	0.00018	0.000219	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRG1—schizophrenia	0.000176	0.000215	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MEF2C—schizophrenia	0.000175	0.000213	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MPC2—schizophrenia	0.000173	0.000211	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—YWHAZ—schizophrenia	0.000169	0.000206	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ERBB3—schizophrenia	0.000165	0.000201	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLCH2—schizophrenia	0.000161	0.000196	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2A—schizophrenia	0.000159	0.000194	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AKT1—schizophrenia	0.000156	0.00019	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NDST3—schizophrenia	0.000151	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—schizophrenia	0.000148	0.00018	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOA1—schizophrenia	0.000146	0.000178	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC27A5—schizophrenia	0.000143	0.000175	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACSL6—schizophrenia	0.000143	0.000175	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ESR1—schizophrenia	0.000141	0.000172	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DAO—schizophrenia	0.000137	0.000167	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PNP—schizophrenia	0.000131	0.00016	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GSK3B—schizophrenia	0.000128	0.000156	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NDUFV2—schizophrenia	0.000122	0.000149	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIP4K2A—schizophrenia	0.000115	0.00014	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP26B1—schizophrenia	0.000104	0.000126	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AKT1—schizophrenia	9.48e-05	0.000116	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TPH1—schizophrenia	9.25e-05	0.000113	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GCLM—schizophrenia	9.25e-05	0.000113	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PRKD1—schizophrenia	8.69e-05	0.000106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AKT1—schizophrenia	8.61e-05	0.000105	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EP300—schizophrenia	8.42e-05	0.000103	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GAPDH—schizophrenia	7.26e-05	8.84e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CLOCK—schizophrenia	7.19e-05	8.77e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TPH2—schizophrenia	7.01e-05	8.54e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CACNB2—schizophrenia	7.01e-05	8.54e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DPYD—schizophrenia	6.89e-05	8.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CACNA1C—schizophrenia	6.41e-05	7.81e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3C2A—schizophrenia	6.25e-05	7.61e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TP53—schizophrenia	6.03e-05	7.34e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP2D6—schizophrenia	5.6e-05	6.83e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SNAP25—schizophrenia	5.6e-05	6.83e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AKT1—schizophrenia	5.09e-05	6.2e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP1A2—schizophrenia	5.07e-05	6.18e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TH—schizophrenia	4.99e-05	6.09e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COMT—schizophrenia	4.25e-05	5.18e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—schizophrenia	4.23e-05	5.15e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MAOA—schizophrenia	4.22e-05	5.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ABCB1—schizophrenia	4e-05	4.88e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLA2G4A—schizophrenia	3.88e-05	4.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—schizophrenia	3.88e-05	4.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—schizophrenia	3.43e-05	4.18e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—schizophrenia	3.19e-05	3.89e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOA1—schizophrenia	3.16e-05	3.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EP300—schizophrenia	1.82e-05	2.22e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—AKT1—schizophrenia	1.1e-05	1.34e-05	CbGpPWpGaD
